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Background LiST is implemented in Spectrum, a modular computer program
designed to examine the impact of interventions on health out-
comes. A typical LiST application uses three other modules in
Spectrum addressing demography, family planning and HIV/AIDS.
Methods The demographic module projects the population by single age and
sex over time and uses LiST calculations of the mortality rates by
age group to calculate the number of deaths. The family planning
module uses the proximate determinants of fertility framework to
calculate the effects of increasing contraceptive use on the total
fertility rate and, thus, the number of births. The HIV/AIDS
module calculates the consequences of HIV epidemic trends on
child mortality and the effects of programs to prevent mother-to-
child transmission of HIV, cotrimoxazole prophylaxis and anti-
retroviral treatment on the number of AIDS deaths.
Results These modules provide LiST with estimates of the number of chil-
dren and number of deaths by single age as they are affected by
changes in fertility through family planning and interventions to
prevent the transmission of HIV or delay AIDS death.
Conclusions Integrating LiST within the existing Spectrum system of planning
models expands the scope of LiST to include the effects of demo-
graphic change, family planning and HIV interventions.
Spectrum system of policy models
Spectrum is a modular computer program used to
examine the consequences of current trends and pro-
gram interventions in health. The core of Spectrum is
a demographic projection model, called DemProj,
1
which projects the population by age and sex. LiST
and other modules interact with the demographic
projection and are included as required for each appli-
cation (Figure 1). These modules address a variety of
issues in additional to maternal and child survival.
The two additional modules used with LiST are
the cost and impact of family planning programs
(FamPlan)
2 and the impacts of HIV/AIDS.
3
Spectrum contains a database of population informa-
tion that provides instant access to the population
estimates and projections for 193 countries and
regions from the United Nations Population
Division
4 (using their projection without AIDS
because the Spectrum AIDS module will add AIDS
mortality) and a database of family planning informa-
tion drawn from Demographic and Health Surveys.
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i7The program and manuals can be downloaded free of
charge from www.HealthPolicyInitiative.com or www
.FuturesInstitute.org. Futures Institute has developed
Spectrum in collaboration with other organizations,
including Futures Group International, USAID,
UNAIDS, WHO and UNICEF.
Demographic projections
The demographic projection component of Spectrum,
DemProj, is a full-featured cohort component projec-
tion model. The inputs are the population by age and
sex in the base year and, for all years in the projec-
tion, the total fertility rate, the age distribution of
fertility, the sex ratio at birth, the life expectancy at
birth in the absence of AIDS, the age pattern of mor-
tality and the number and distribution by age and sex
of international migrants.
A standard demographic projection with DemProj
includes a model life table that provides information
on mortality by single age for any value of life expec-
tancy at birth. The standard tables are the four Coale–
Demeny tables (north, south, east and west) and the
five United National tables (General, Latin America,
Chile, South Asia and East Asia). When used with
LiST, DemProj searches for the value of life expectancy
at birth that corresponds to the correct infant and
under-five mortality rates within the chosen life table.
At the beginning of each projection year, DemProj
provides LiST with the number of deaths for children
aged 0, 1, 2, 3 and 4 years. LiST disaggregates those
deaths into its age bands: 0–1, 1–5, 6–11, 12–23 and
24–59 months by fitting a double log function to
the neonatal, infant and under-five mortality rates.
The equation has the form ln(u)¼aþb ln(age)þ
c age ln(age) where u is the cumulative mortality
at the corresponding age.
Once LiST calculates the impact of interventions on
the child mortality rates, they are converted to ages 0,
1, 2, 3 and 4 years and sent back to DemProj that uses
these new rates to determine the number of children
surviving to the following year.
DemProj calculates the number of births each year
from the number of women 15–49 years old, the total
fertility rate and the age distribution of fertility. New
births are subject to the estimated mortality rates as
they age each year. The number of live births is multi-
plied by the maternal mortality ratio from LiST to
determine the number of maternal deaths.
Impact of family planning on
maternal and child survival
Increased use of modern contraception reduces the
number of births that would otherwise occur, and,
therefore, reduces the number of child deaths. The
current version of LiST does not include the effects
of increased contraceptive use on child mortality
rates but that relationship will be included in future
versions. Family planning can affect the number of
maternal deaths by reducing the total number of
births (reducing exposure to the risk of maternal
mortality) and by reducing the number of unsafe
abortions that result from unintended pregnancies
and thereby reducing the maternal mortality ratio.
Figure 1 Interactions between LiST and other modules in Spectrum
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uses the proximate determinants of fertility frame-
work to relate contraceptive use to the total fertility
rate.
6 This framework describes the factors that deter-
mine the observed total fertility rate: marriage, post-
partum insusceptibility, abortion, pathological sterility
and contraception. The basic model is:
TFR ¼Cm Ci Ca Cp Cc TF ð1Þ
where Cm is the index of marriage, Ci is the index of
postpartum insusceptibility, Ca is the index of induced
abortion, Cp is the index of pathological sterility, Cc
is the index of contraception and TF is total fecundity.
Total fecundity is the average number of births
women would have during their lifetimes if there
were nothing acting to restrict their fertility. It is gen-
erally estimated to be around 13–18. The other prox-
imate determinants act to produce an observed TFR
that is lower than the total fecundity rate.
The indexes for the other factors are calculated as
follows:
Cm¼ proportion married or in union ð2Þ
Ci¼ 20=ð18:5 þ iÞð 3Þ
where i¼average duration of postpartum insuscepti-
bility in months
Ca¼ TFR=fTFR þ 0:4  ð 1þuÞ TARgð 4Þ
where TAR¼total abortion rate
Cp¼ð 7:63   0:11   sÞ=7:3 ð5Þ
where s¼percentage of women 45–49 years of age
who have had no live births
Cc¼ 1   1:08   u   e ð6Þ
In the equation for the contraception index, Cc, u
represents contraceptive prevalence, the proportion
of married women of reproductive age using contra-
ception, whereas e represents the average effectiveness
of contraception, which is a weighted average of
the effectiveness of each method and the proportion
of women using each method. Standard values for
method effectiveness are shown in Table 1.
7
Equation (1) is rearranged to calculate the total
fecundity, TF, in the base year from all of the other
inputs. The value of TF is assumed to remain constant
during the projection period. Thus, for future years,
Equation (1) can used to determine the total fertility
rate from the other inputs. If the other proximate
determinants remain constant, then TFR is deter-
mined by contraceptive prevalence and the distribu-
tion of women by the contraceptive method.
Most of the data required for FamPlan are avail-
able from national household surveys such as the
Demographic and Health Surveys. These provide
information on TFR, the proportion married or in
union, the duration of post-partum insusceptibility,
the proportion of women aged 45–49 years with no
live births, the proportion of women using contracep-
tion and the method mix. Information on the total
abortion rate is difficult to get in most countries,
but it can also be modelled as the percentage of unin-
tended pregnancies terminated by abortion, where
unintended pregnancies are those occurring to women
who do not want another birth now. Regional estimates
of abortion rates may be used where country-specific
estimates are not available.
Impact of AIDS interventions
on child survival
The AIDS Impact Module (AIM) uses a projection
of adult HIV incidence derived from surveillance
and survey data to project the course of the HIV epi-
demic.
8,9 It estimates new adult infections by age and
sex and tracks them as they progress from initial
infection, to need for treatment and to AIDS death.
HIV-infected mothers can pass infection to their chil-
dren at the time of birth or post-natally through
breastfeeding. Infected children progress over time
from new infection to AIDS death with those infected
perinatally progressing more rapidly than those
infected through breastfeeding.
AIM contains three interventions that affect the
number of AIDS deaths among children: anti-
retroviral prophylaxis to prevent mother-to-child
transmission, cotrimoxazole to reduce susceptibility
to infectious diseases and anti-retroviral therapy
(ART) to slow the progression of HIV disease.
Births to HIV-positive women are calculated from
the number of HIV-positive women by age, the total
fertility rate and the proportion of lifetime births that
occur in that age group. The fertility of HIV-positive
women is adjusted for the effects of HIV infection on
fertility.
10
The transmission of HIV from mother to child is
divided into two components: transmission during
gestation and delivery, and postnatal transmission
through breastfeeding. The probabilities of HIV trans-
mission are shown in Table 2.
Table 1 Contraceptive method effectiveness
Method Effectiveness (%)
Pill 92
IUD 96
Barrier methods 81
Withdrawal or rhythm 50
Norplant 100
Injectable 100
Sterilization 100
Stover et al.
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LINKING MATERNAL AND CHILD SURVIVAL INTERVENTIONS i9In the absence of treatment, children infected at birth
progress to AIDS death at a rapid rate (median of
1 year) with only  5% surviving to age 5 years, whereas
those infected through breastfeeding progress at a
much slower rate (median of 15 years).
11
Cotrimoxazole is recommended for all HIV-exposed
children under the age of 18 months (i.e. uninfected
children with an infected mother and still breastfeed-
ing) and all HIV-infected children under the age of
5 years.
12 The effectiveness of cotrimoxazole in avert-
ing AIDS deaths among children is shown in Table 3.
All HIV-positive children under the age of 1 year are
in need of treatment. After the age of 1 year, children
need treatment once they progress to moderate-
to-severe disease.
13 Annual survival on ART is 80%
for children under the age of 1 year. For those over
the age of 1 year, it is 85% in the first year on ART
and 93% in each subsequent year.
14
Discussion
Integrating LiST within the existing Spectrum system
of planning models expands the scope of LiST to
include the effects of demographic change, family
planning and HIV interventions. This also expands
the data requirements to fully utilize LiST and users
involved in planning child survival interventions may
not be expert in family planning or HIV. To address
this issue, LiST includes prepared datasets for
FamPlan and AIM for most countries. This allows a
fuller exploration of the actions that can be taken to
reduce child mortality in resource-limited settings.
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Table 2 Probabilities of mother-to-child transmission
Type of prophylaxis
Probability of
perinatal
transmission (%)
None 20
Single-dose nevirapine 11
Dual ARVs 4
Triple ARVs 2
Type of infant feeding Monthly probability
of HIV transmission
(%)
Exclusive breastfeeding,
0–5 months
0.75
Mixed feeding (breastfeeding
and other foods), 0–5 months
1.5
Mixed feeding, 6–35 months 0.75
Mother receiving ART 0.3
Consultative Meeting on Data Collection and Estimation
Methods Related to HIV Infection in Infants and Children.
14
Table 3 Reduction in AIDS mortality due to
cotrimoxazole
Year 1 Year 2 Year 3 Year 4 Year 5
Cotrimoxazole
alone (%)
33 33 33 33 33
Cotrimoxazole
and ART (%)
33 16 8 0 0
Consultative Meeting on Data Collection and Estimation
Methods Related to HIV Infection in Infants and Children.
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